Shifa Biomedical Corp
Shifa Biomedical Corporation, based in Malvern, Pennsylvania, is a privately held biopharmaceutical company focused on the cost-effective development of drugs for cardiovascular disease. Established in 2006, the company specializes in the discovery of small molecule drugs, leveraging expertise in molecular biology, biochemistry, and medicinal chemistry.
Shifa's most advanced compound targets dyslipidemia, aiming to significantly lower bad cholesterol (LDL-C) levels. By pursuing innovative approaches to regulate the PCSK9 protein, Shifa is developing a first-in-class oral small molecule therapy that could provide an effective alternative to existing injectable treatments.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.

